999 results on '"Koopmans, Marion P. G."'
Search Results
2. An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution
3. In vitro and in vivo characterization of a novel West Nile virus lineage 2 strain
4. Accessible viral metagenomics for public health and clinical domains with Jovian
5. Determinants of intended prevention behaviour against mosquitoes and mosquito-borne viruses in the Netherlands and Spain using the MosquitoWise survey: cross-sectional study
6. SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity
7. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
8. Correction: The One Health High-Level Expert Panel (OHHLEP)
9. Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients
10. Development and validation of the MosquitoWise survey to assess perceptions towards mosquitoes and mosquito-borne viruses in Europe
11. The panzootic spread of highly pathogenic avian influenza H5N1 sublineage 2.3.4.4b: a critical appraisal of One Health preparedness and prevention
12. The One Health High-Level Expert Panel (OHHLEP)
13. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up
14. Combining epidemiological data and whole genome sequencing to understand SARS-CoV-2 transmission dynamics in a large tertiary care hospital during the first COVID-19 wave in The Netherlands focusing on healthcare workers
15. Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variants
16. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial
17. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals
18. An early warning system for emerging SARS-CoV-2 variants
19. Defining the risk of SARS-CoV-2 variants on immune protection
20. A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies.
21. A three-dimensional vessel-on-chip model to study Puumala orthohantavirus pathogenesis.
22. Agile, on-demand wastewater surveillance of virus infections to support pandemic and outbreak response in Rotterdam-Rijnmond, the Netherlands, 2020 to 2022.
23. Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
24. Profiling of humoral immune responses to norovirus in children across Europe
25. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants
26. Establishing farm dust as a useful viral metagenomic surveillance matrix
27. Towards reliable whole genome sequencing for outbreak preparedness and response
28. SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation
29. Worldwide Trends in COVID-19-Related Attacks Against Healthcare: A Review of the Safeguarding Health in Conflict Coalition Database
30. mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
31. Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.
32. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study
33. Fast-forwarding collaborative surveillance
34. Effectiveness of Passive and Active Surveillance for Early Detection of SARS-CoV-2 in Mink during the 2020 Outbreak in the Netherlands
35. Early Measles Vaccination During an Outbreak in the Netherlands : Short-Term and Long-Term Decreases in Antibody Responses Among Children Vaccinated Before 12 Months of Age
36. Zika Virus Seroprevalence in Urban and Rural Areas of Suriname, 2017
37. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
38. Effectiveness of Passive and Active Surveillance for Early Detection of SARS-CoV-2 in Mink during the 2020 Outbreak in the Netherlands
39. Ixodes ricinus as potential vector for Usutu virus
40. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters
41. Bacteriophage therapy reduces Staphylococcus aureus in a porcine and human ex vivo burn wound infection model
42. Effectiveness of Passive and Active Surveillance for Early Detection of SARS-CoV-2 in Mink during the 2020 Outbreak in the Netherlands
43. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
44. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
45. Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands
46. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
47. West Nile virus spread in Europe: Phylogeographic pattern analysis and key drivers
48. H1N1pdm09 Influenza Virus and Its Descendants Lack Extra-epitopic Amino Acid Residues Associated With Reduced Recognition by M1 58-66 -Specific CD8 + T Cells
49. Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
50. Molecular surveillance of norovirus, 2005–16: an epidemiological analysis of data collected from the NoroNet network
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.